FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to experimental and preclinical studies, and can be used to simulate chronic ischemia in experimental animals. The femoral artery is visualized using computed tomography or magnetic resonance imaging. The femoral artery is irradiated with ionizing radiation on a stereotaxic radiation therapy unit with a single fraction with a total focal dose of 20-25 Gy.
EFFECT: method ensures the absence of surgical risks, high conformity and the development of ischemia along the physiological path due to exposure to ionizing radiation.
1 cl, 3 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR SIMULATING RADIATION PULMONITIS IN EXPERIMENT | 2023 |
|
RU2816074C1 |
METHOD OF TREATING CHRONIC LIMB ISCHEMIA EXPERIMENTALLY | 2014 |
|
RU2556606C1 |
MEDICATION FOR TREATMENT OF CARDIOVASCULAR DISEASES | 2014 |
|
RU2555335C9 |
DERIVATIVE OF IMIDAZO-[1,2A]-BENZIMIDAZOLE - AGENT PRODUCING CEREBROPROTECTIVE EFFECT IN RADIATION INJURES | 2001 |
|
RU2238938C2 |
DRUG WITH COMPLEX PHARMACOLOGICAL EFFECT FOR THE TREATMENT OF CARDIOVASCULAR DISEASES, CORRECTION OF CEREBRAL CIRCULATION DISORDERS, TREATMENT OF CONSEQUENCES OF CEREBROVASCULAR DISEASES (OPTIONS) | 2019 |
|
RU2757874C1 |
METHOD OF EXTREMITY ISCHEMIA SIMULATION | 2019 |
|
RU2734568C1 |
METHOD FOR EXPERIMENTAL ESTABLISHMENT OF THROMBOSED VEIN FLOW | 2012 |
|
RU2490722C1 |
METHOD FOR PHARMACOLOGICAL CORRECTION OF EXPERIMENTAL CRITICAL SKELETAL MUSCLE ISCHEMIA WITH A COMBINATION OF SIMVASTATIN AND MONONUCLEAR FRACTION OF AUTOLOGOUS BONE MARROW | 2020 |
|
RU2735838C1 |
RADIATION CYSTITIS MODELING METHOD | 2018 |
|
RU2676431C1 |
METHOD FOR PHARMACOLOGICAL STIMULATION OF NEOANGIOGENESIS IN TREATING ACUTE EXPERIMENTAL LIMB ISCHEMIA | 2014 |
|
RU2559937C1 |
Authors
Dates
2022-08-01—Published
2022-03-02—Filed